PE firm TPG Capital said to mull stake sale in IPO-bound Pathology Asia
Private equity firm TPG Capital Asia is considering selling a 20% stake in Pathology Asia Holdings, its pathology business in the region.
Source: dealstreetasia.com
Stay updated with breaking news from Safeworks Laboratories. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Private equity firm TPG Capital Asia is considering selling a 20% stake in Pathology Asia Holdings, its pathology business in the region.